Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.41 |
| ▸ | FPR2 | P25090 | 6/20 | 0.41 |
| ▸ | FPR3 | P25089 | 2/20 | 0.39 |
| ▸ | RORC | P51449 | 2/20 | 0.39 |
| ▸ | NAMPT | P43490 | 1/20 | 0.39 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.36 |
| ▸ | IGF1R | P08069 | 1/20 | 0.36 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31454988 | 0.82 | MAPK1 (0.43) | FPR2MAPTMKNK1SLC34A1 | |
| SCHEMBL31455504 | 0.82 | MKNK1 (0.40) | FPR2NAMPTALDH1A1LMNAMAPT | |
| SCHEMBL15342504 | 0.82 | USP30 (0.45) | USP30FPR2FPR3RORCALDH1A1 | |
| SCHEMBL31455531 | 0.82 | GPR119 (0.43) | NAMPTALDH1A1LMNAMAPT | |
| SCHEMBL30273842 | 0.81 | MAPT (0.44) | USP30RORCNAMPTPDE4BALDH1A1 | |
| SCHEMBL31237115 | 0.79 | NAMPT (0.50) | USP30NAMPTALDH1A1MAPTIGF1R | |
| SCHEMBL31144715 | 0.78 | PRMT1 (0.46) | ALDH1A1LMNAMAPT | |
| SCHEMBL15187965 | 0.77 | RORC (0.56) | USP30FPR2FPR3RORCNAMPT | |
| SCHEMBL31455485 | 0.77 | ALDH1A1 (0.44) | USP30RORCPDE4BALDH1A1LMNA | |
| SCHEMBL25273382 | 0.77 | FPR2 (0.47) | USP30FPR2FPR3ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059577-A1 | SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS | ATAVISTIK BIO, INC. (US) | 2025-03-20 | — | — | WO | disclosed |